These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26547419)

  • 1. Technologies to develop new metal medicines.
    Dufrasne F
    Drug Discov Today Technol; 2015 Sep; 16():31-2. PubMed ID: 26547419
    [No Abstract]   [Full Text] [Related]  

  • 2. Overview.
    Prudhomme M
    Anticancer Agents Med Chem; 2017; 17(1):2. PubMed ID: 28143383
    [No Abstract]   [Full Text] [Related]  

  • 3. Rhodium complexes as therapeutic agents.
    Ma DL; Wang M; Mao Z; Yang C; Ng CT; Leung CH
    Dalton Trans; 2016 Feb; 45(7):2762-71. PubMed ID: 26743935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The progresses in curcuminoids-based metal complexes: especially in cancer therapy.
    Zhang Y; Khan AR; Fu M; Zhai Y; Yu A; Zhai G
    Future Med Chem; 2019 May; 11(9):1035-1056. PubMed ID: 31140861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Perspective - can copper complexes be developed as a novel class of therapeutics?
    Wehbe M; Leung AWY; Abrams MJ; Orvig C; Bally MB
    Dalton Trans; 2017 Aug; 46(33):10758-10773. PubMed ID: 28702645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capillary electrophoresis in metallodrug development.
    Holtkamp H; Hartinger CG
    Drug Discov Today Technol; 2015 Sep; 16():16-22. PubMed ID: 26547417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs.
    Liu W; Gust R
    Chem Soc Rev; 2013 Jan; 42(2):755-73. PubMed ID: 23147001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Speciation of precious metal anti-cancer complexes by NMR spectroscopy.
    Zou T; Sadler PJ
    Drug Discov Today Technol; 2015 Sep; 16():7-15. PubMed ID: 26547416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Natural Product-Conjugated Metal Complexes as Cancer Therapies.
    Ma DL; Wu C; Cheng SS; Lee FW; Han QB; Leung CH
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30650627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trapping unstable benzoquinone analogues by coordination to a [(η(5)-C(5)Me(5))Ir] fragment and the anticancer activity of the resulting complexes.
    Hartinger CG
    Angew Chem Int Ed Engl; 2010 Nov; 49(45):8304-5. PubMed ID: 20803595
    [No Abstract]   [Full Text] [Related]  

  • 11. N-heterocyclic carbene metal complexes as bio-organometallic antimicrobial and anticancer drugs.
    Patil SA; Patil SA; Patil R; Keri RS; Budagumpi S; Balakrishna GR; Tacke M
    Future Med Chem; 2015; 7(10):1305-33. PubMed ID: 26144266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in copper complexes as anticancer agents.
    Santini C; Pellei M; Gandin V; Porchia M; Tisato F; Marzano C
    Chem Rev; 2014 Jan; 114(1):815-62. PubMed ID: 24102434
    [No Abstract]   [Full Text] [Related]  

  • 13. Frontiers in Medicinal Chemistry 2010: the highlights.
    Schepmann D; Wünsch B
    ChemMedChem; 2010 Jun; 5(6):949-54. PubMed ID: 20461748
    [No Abstract]   [Full Text] [Related]  

  • 14. Special focus: metals in medicine.
    Spencer J; Walden B
    Future Med Chem; 2018 Mar; 10(6):607-609. PubMed ID: 29508658
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent researches in metal supramolecular complexes as anticancer agents.
    Zhou CH; Zhang YY; Yan CY; Wan K; Gan LL; Shi Y
    Anticancer Agents Med Chem; 2010 Jun; 10(5):371-95. PubMed ID: 20380632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breakthrough programme turns two.
    Mullard A
    Nat Rev Drug Discov; 2014 Dec; 13(12):873-5. PubMed ID: 25435204
    [No Abstract]   [Full Text] [Related]  

  • 17. Metal/N-heterocyclic carbene complexes: opportunities for the development of anticancer metallodrugs.
    Cisnetti F; Gautier A
    Angew Chem Int Ed Engl; 2013 Nov; 52(46):11976-8. PubMed ID: 24115500
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiproliferative activity of dmoPTA-Ru(II) complexes against human solid tumor cells.
    Ríos-Luci C; León LG; Mena-Cruz A; Pérez-Roth E; Lorenzo-Luis P; Romerosa A; Padrón JM
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4568-71. PubMed ID: 21719285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porphyrin complexes of the period 6 main group and late transition metals.
    Lemon CM; Brothers PJ; Boitrel B
    Dalton Trans; 2011 Jul; 40(25):6591-609. PubMed ID: 21384031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening technologies for ion channel drug discovery.
    Terstappen GC; Roncarati R; Dunlop J; Peri R
    Future Med Chem; 2010 May; 2(5):715-30. PubMed ID: 21426199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.